Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
412,914,375
-
Total 13F shares
-
3,249,704
-
Share change
-
-35,604
-
Total reported value
-
$8,092,000
-
Price per share
-
$2.49
-
Number of holders
-
13
-
Value change
-
-$130,379
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q3 2022
As of 30 Sep 2022 Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) had 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,249,704 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Cormorant Asset Management, LP, Ikarian Capital, LLC, BOOTHBAY FUND MANAGEMENT, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, ENVESTNET ASSET MANAGEMENT INC, Activest Wealth Management, and ADVISOR GROUP HOLDINGS, INC..
This table shows 13 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.